Clinicians’ Guide to Cannabidiol and Hemp Oils
Open Access
- 21 August 2019
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 94 (9), 1840-1851
- https://doi.org/10.1016/j.mayocp.2019.01.003
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymesBritish Journal of Pharmacology, 2010
- Inhibition of microsomal prostaglandin E2 synthase‐1 as a molecular basis for the anti‐inflammatory actions of boswellic acids from frankincenseBritish Journal of Pharmacology, 2010
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1and CB2Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2010
- Non‐psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of actionBritish Journal of Pharmacology, 2010
- Phytocannabinoids beyond the Cannabis plant – do they exist?British Journal of Pharmacology, 2010
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal DisturbancesJournal of Neuroscience, 2009
- Beta-caryophyllene is a dietary cannabinoidProceedings of the National Academy of Sciences of the United States of America, 2008
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006